Frontlight ResearchEarly access
Trial site
Nanshi Hospital of Nanyang
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Stroke8 trials
- Phase
- Phase 25 trials
- Phase 33 trials
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Beijing Tiantan Hospital1 trial
- Janssen Research & Development, LLC1 trial
- Kunming Pharmaceuticals, Inc.1 trial
- Shanghai Hutchison Pharmaceuticals Limited1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Recruiting
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke4 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026